Sigma Planning Corp Boosts Stake in Tempus AI, Inc. (NASDAQ:TEM)

Sigma Planning Corp increased its holdings in shares of Tempus AI, Inc. (NASDAQ:TEM) by 43.9% during the fourth quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission (SEC). The institutional investor owned 33,638 shares of the company’s stock after purchasing an additional 10,269 shares during the quarter. Sigma Planning Corp’s holdings in Tempus AI were worth $1,136,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

Other large investors also recently bought and sold shares of the company. Private Advisor Group LLC bought a new position in Tempus AI during the 4th quarter valued at about $1,344,000. Apollon Wealth Management LLC bought a new stake in shares of Tempus AI in the fourth quarter worth approximately $256,000. Sumitomo Mitsui Trust Group Inc. raised its holdings in shares of Tempus AI by 166.0% during the fourth quarter. Sumitomo Mitsui Trust Group Inc. now owns 3,239,093 shares of the company’s stock valued at $109,352,000 after purchasing an additional 2,021,394 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. bought a new position in Tempus AI during the fourth quarter valued at approximately $178,000. Finally, James J. Burns & Company LLC purchased a new stake in Tempus AI in the fourth quarter worth approximately $236,000. 24.22% of the stock is currently owned by institutional investors.

Insider Activity

In related news, major shareholder Bradley A. Keywell sold 395,800 shares of the firm’s stock in a transaction on Wednesday, December 11th. The shares were sold at an average price of $42.95, for a total transaction of $16,999,610.00. Following the completion of the transaction, the insider now directly owns 16,164,449 shares of the company’s stock, valued at approximately $694,263,084.55. This trade represents a 2.39 % decrease in their ownership of the stock. The transaction was disclosed in a legal filing with the SEC, which is accessible through this link. Also, CAO Ryan M. Bartolucci sold 13,770 shares of Tempus AI stock in a transaction on Friday, January 31st. The shares were sold at an average price of $60.00, for a total transaction of $826,200.00. Following the completion of the sale, the chief accounting officer now owns 57,237 shares in the company, valued at approximately $3,434,220. This represents a 19.39 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold 2,583,467 shares of company stock worth $130,542,311 over the last ninety days.

Tempus AI Stock Performance

NASDAQ TEM opened at $69.57 on Tuesday. Tempus AI, Inc. has a 12 month low of $22.89 and a 12 month high of $91.45. The company’s 50 day moving average is $50.88 and its two-hundred day moving average is $52.03. The company has a debt-to-equity ratio of 8.17, a quick ratio of 2.55 and a current ratio of 2.69.

Tempus AI (NASDAQ:TEM) last announced its quarterly earnings data on Monday, February 24th. The company reported ($0.33) EPS for the quarter, missing the consensus estimate of ($0.15) by ($0.18). As a group, equities research analysts expect that Tempus AI, Inc. will post -6.15 EPS for the current fiscal year.

Analyst Ratings Changes

A number of brokerages have weighed in on TEM. Wolfe Research started coverage on shares of Tempus AI in a research note on Friday, December 13th. They set an “outperform” rating and a $60.00 target price for the company. William Blair cut Tempus AI from an “outperform” rating to a “market perform” rating in a research report on Wednesday, February 12th. Piper Sandler reissued a “neutral” rating and issued a $70.00 target price (up from $40.00) on shares of Tempus AI in a research report on Tuesday, November 12th. Guggenheim initiated coverage on Tempus AI in a research note on Monday, December 9th. They set a “buy” rating and a $74.00 price target for the company. Finally, Loop Capital lowered their price objective on shares of Tempus AI from $57.00 to $52.00 and set a “buy” rating on the stock in a research note on Tuesday, January 14th. Four equities research analysts have rated the stock with a hold rating and eight have given a buy rating to the stock. Based on data from MarketBeat, Tempus AI presently has a consensus rating of “Moderate Buy” and a consensus target price of $58.55.

Tempus AI Company Profile

Tempus AI Inc is a technology company advancing precision medicine through the practical application of artificial intelligence principally in healthcare. The company provides AI-enabled precision medicine solutions to physicians to deliver personalized patient care and in parallel facilitates discovery, development and delivery of optimal therapeutics.